$4.3 billion Biogen Idec has announced the appointment of two new members to its board: Eric Rowinsky and Stephen Sherwin. Icahn Partners, led by activist investor Carl Icahn, proposed Rowinsky as a nominee, while Sherwin was selected by the company.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...